Use of ICTs in emergency medicine: assessment of a prescription aid software for patients with hyperglycemia (DIAGETHER®), by resident doctors
DOI:
https://doi.org/10.19230/jonnpr.3599Keywords:
Decision support software, treatment, medical application, DIAGETHER, type 2 diabetesAbstract
Introduction. Permissiveness to hyperglycemia is harmful to admitted patients. DIAGETHER is an application that helps the doctor in the treatment of the diabetic patient.
Objectives. Determine degree of usability, level of confidence and overall assessment of DIAGETHER used by physicians resident in different clinical settings.
Method. Multicenter descriptive study, based on a DIAGETHER assessment survey, of 42 residents of two hospitals, assessing decision-making regarding the therapeutics of patients with glycemic disorders in different clinical settings.
Results. DIAGETHER was positively assessed regarding usability, confidence in case resolution, and time spent. The overall assessment of the tool was 87.5. On the negative side, it is necessary to conduct real-field studies to know the real adaptation of the tool to medical work.
Conclusions. The DIAGETHER® application is an easy-to-use, quick decision-making tool and gives the doctor safety in the treatment of patients with hyperglycemia, which makes their overall assessment high. On the negative side, the study was conducted under “non-real” conditions, it would be interesting to develop future studies in several emergency departments.
Downloads
References
Carballo Cardona C, Tang H, Borobia A, Tung Y, Guillén Astete C. Estudio de costes tras una única intervención mediante una aplicación informática (DIAGETHER) en el tratamiento de los pacientes diabéticos que ingresan en un hospital de tercer nivel. JONNPR. 2018;3(1):8-14.
Álvarez-Rodríguez E, Laguna Morales I, Rosende Tuya A, Tapia Santamaría R, Martín Martínez A, López Riquelme P, et al. Frequency and management of diabetes and hyperglycemia at emergency departments: the GLUCE-URG Study. Endocrinol Diabetes Nutr. febrero de 2017;64(2):67-74.
Mata-Cases M, Antoñanzas F, Tafalla M, Sanz P. The cost of type 2 diabetes in Spain: the CODE-2 study. Gac Sanit SESPAS. 30 de noviembre de 2001;16:511-20.
Zelihic E, Poneleit B, Siegmund T, Haller B, Sayk F, Dodt C. Hyperglycemia in emergency patients--prevalence and consequences: results of the GLUCEMERGE analysis. Eur J Emerg Med Off J Eur Soc Emerg Med. junio de 2015;22(3):181-7.
Griffith ML, Boord JB, Eden SK, Matheny ME. Clinical inertia of discharge planning among patients with poorly controlled diabetes mellitus. J Clin Endocrinol Metab. junio de 2012;97(6):2019-26.
Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. marzo de 2002;87(3):978-82.
Carballo Cardona C, Gallego Rodríguez P, Alba LW, Zamorano Serrano M, Estévez Rueda MJ, Fernández C. Adherencia de los Urgenciólogos al protocolo de Control Glucémico de la Herramienta GLIKAL©. JONNPR. 1(1):1-42.
Ampudia-Blasco FJ, García-Soidán FJ, Rubio Sánchez M, Phan T-M. Validation in daily clinical situations of Diascope(®), a software developed to help healthcare professionals individualize antidiabetic treatment in type 2 diabetes. Endocrinol Diabetes Nutr. marzo de 2017;64(3):128-37.
Aloi J, Bode BW, Ullal J, Chidester P, McFarland RS, Bedingfield AE, et al. Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting. J Diabetes Sci Technol. enero de 2017;11(1):12-6.
Tanenberg RJ, Hardee S, Rothermel C, Drake AJ 3rd. USE OF A COMPUTER-GUIDED GLUCOSE MANAGEMENT SYSTEM TO IMPROVE GLYCEMIC CONTROL AND ADDRESS NATIONAL QUALITY MEASURES: A 7-YEAR, RETROSPECTIVE OBSERVATIONAL STUDY AT A TERTIARY CARE TEACHING HOSPITAL. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. marzo de 2017;23(3):331-41.
Sáenz A, Brito M, Morón I, Torralba A, García-Sanz E, Redondo J. Development and validation of a computer application to aid the physician’s decision-making process at the start of and during treatment with insulin in type 2 diabetes: a randomized and controlled trial. J Diabetes Sci Technol. 1 de mayo de 2012;6(3):581-8.
Cuervo Pinto R, Álvarez-Rodríguez E, González Pérez de Villar N, Artola-Menéndez S, Girbés Borrás J, Mata-Cases M, et al. Managing the discharge of diabetic patients from the emergency department: a consensus paper. Emerg Rev Soc Espanola Med Emerg. octubre de 2017;29(5):343-51.
Álvarez-Rodríguez E, Agud Fernández M, Caurel Sastre Z, Gallego Mínguez I, Carballo Cardona C, Juan Arribas A, et al. Recommendations for the management of emergencies in patients with diabetes, acute metabolic complications of diabetes, and steroid-related hyperglycemia. Emerg Rev Soc Espanola Med Emerg. 2016;28(6):400-17.
Alemán Sánchez JJ, Artola Menéndez S, Franch Nadal J, Mata Cases M, Millaruelo Trillo JM, Sangrós González FJ. Recomendaciones para el tratamiento de la diabetes mellitus tipo 2: control glucémico. Diabetes Práctica. 2014;5(1):18-20.
Artola Menéndez S, García Soidán J, Navarro Pérez J, Goday Arno A, Gorgojo Martínez JJ, Martín González E, et al. Consenso para la insulinización de pacientes con diabetes mellitus tipo 2. Diabetes Práctica. 2014;5(1):20-9.
Carballo Cardona C, Gallego Rodríguez P. Ensayo clínico multicéntrico para la validación de la aplicación Glikal en la ayuda al manejo de la hiperglucemia en comparación con la práctica clínica habitual.
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License